When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Rituximab - Wikipedia

   en.wikipedia.org/wiki/Rituximab

   Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...

3. EPOCH (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/EPOCH_(chemotherapy)

   Rituximab: an anti-CD20 monoclonal antibody, which has the ability to kill B cells, be they normal or malignant; Etoposide : a topoisomerase inhibitor from the group of epipodophyllotoxins; Prednisolone : a glucocorticoid hormone that can cause apoptosis and lysis of both normal and malignant lymphocytes ;

4. Chemotherapy regimen - Wikipedia

   en.wikipedia.org/wiki/Chemotherapy_regimen

   rituximab + bendamustine: follicular lymphoma and MALT lymphoma [7] R-DHAP or DHAP-R: rituximab + DHAP; that is, rituximab, dexamethasone (a steroid hormone), cytarabine (ara-C), platinum agent: relapsed non-Hodgkin's lymphoma and Hodgkin's lymphoma R-FCM or FCM-R: rituximab + FCM; that is, rituximab, fludarabine, cyclophosphamide, mitoxantrone

5. Monoclonal antibody - Wikipedia

   en.wikipedia.org/wiki/Monoclonal_antibody

   The translational work needed to implement these ideas is credited to Lee Nadler. As explained in an NIH article, "He was the first to discover monoclonal antibodies directed against human B-cell–specific antigens and, in fact, all the known human B-cell–specific antigens were discovered in his laboratory.

6. CHOP (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/CHOP_(chemotherapy)

   This regimen can also be combined with the monoclonal antibody rituximab if the lymphoma is of B cell origin; this combination is called R-CHOP. In 2002, a randomized controlled trial showed a higher complete response rate for R-CHOP vs CHOP in elderly patients with Diffuse Large-B-Cell Lymphoma (76% vs 63%). [ 4 ]

7. A noninvasive cheek swab test could help predict aging, risk ...

   www.aol.com/noninvasive-cheek-swab-test-could...

   Scientists have long known that aging varies widely among individuals, influenced by genetics and lifestyle choices. Now, a new tool called CheekAge offers a simple, noninvasive way to predict ...